XML 38 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill and Other Intangible Assets (Tables)
6 Months Ended
Jun. 29, 2014
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The following table provides the components of and changes in the carrying amount of Goodwill:
(MILLIONS OF DOLLARS)
 
GIP
 
VOC
 
GEP
 
To be Allocated(a)

 
Total

Balance, December 31, 2013
 
$
 
$
 
$
 
$
42,519

 
$
42,519

Additions
 

 

 

 

 

Other(b)
 

 

 

 
142

 
142

Balance, June 29, 2014
 
$
 
$
 
$
 
$
42,661

 
$
42,661


(a) 
The amount to be allocated includes the goodwill associated with our former biopharmaceutical operating segments (see above), for which the allocation to our new reporting units, and, as a result, to the new operating segments, is pending.
(b) 
Primarily reflects the impact of foreign exchange.
Schedule of Finite Lived And Indefinite Lived Intangible Assets
The following table provides the components of Identifiable intangible assets:
 
 
June 29, 2014
 
December 31, 2013
(MILLIONS OF DOLLARS)
 
Gross
Carrying
Amount

 
Accumulated
Amortization

 
Identifiable
Intangible
Assets, less
Accumulated
Amortization

 
Gross
Carrying
Amount

 
Accumulated
Amortization

 
Identifiable
Intangible
Assets, less
Accumulated
Amortization

Finite-lived intangible assets
 
 
 
 
 
 
 
 
 
 
 
 
Developed technology rights
 
$
72,030

 
$
(43,599
)
 
$
28,431

 
$
72,038

 
$
(41,541
)
 
$
30,497

Brands
 
1,944

 
(815
)
 
1,129

 
1,743

 
(773
)
 
970

Licensing agreements and other
 
921

 
(824
)
 
97

 
896

 
(805
)
 
91

 
 
74,895

 
(45,238
)
 
29,657

 
74,677

 
(43,119
)
 
31,558

Indefinite-lived intangible assets
 
 
 
 
 
 
 
 
 
 
 
 
Brands and other
 
7,374

 


 
7,374

 
7,384

 


 
7,384

In-process research and development
 
329

 


 
329

 
443

 


 
443

 
 
7,703

 


 
7,703

 
7,827

 


 
7,827

Identifiable intangible assets(a)
 
$
82,598

 
$
(45,238
)
 
$
37,360

 
$
82,504

 
$
(43,119
)
 
$
39,385

(a) 
The decrease in identifiable intangible assets, less accumulated amortization, is primarily related to amortization and, to a much lesser extent, asset impairment charges, partially offset by the Nexium over-the-counter milestone. For information about impairments of intangible assets, see Note 4. Other (Income)/Deductions—Net. For information about the Nexium over-the-counter milestone, see Note 2A. Acquisition, Divestiture, Collaborative Arrangement and Equity-Method Investments: Acquisition.
Identifiable intangible assets as a percentage of total identifiable intangible assets less accumulated amortization, by segment [Table Text Block]
Our identifiable intangible assets are associated with the following, as a percentage of total identifiable intangible assets, less accumulated amortization:
 
 
June 29, 2014
 
 
GIP
 
VOC
 
GEP
 
WRD(a)
Developed technology rights
 
34
%
 
32
%
 
34
%
 
%
Brands, finite-lived
 
%
 
80
%
 
20
%
 
%
Brands, indefinite-lived
 
%
 
69
%
 
31
%
 
%
In-process research and development
 
9
%
 
58
%
 
9
%
 
24
%
(a) 
Worldwide Research and Development.